VIRTUAL | Connecting the dots: genomic tumor testing, targeted treatments and patient care
The Maine Cancer Genomics Initiative at The Jackson Laboratory is pleased to offer a special virtual event on genomic tumor testing for oncology nurses, clinical research coordinators, and other interested clinicians in Maine.
This CNE-accredited interactive program will cover:
- which patients can benefit most from genomic tumor testing
- addressing patient questions and misconceptions about testing
- identifying targeted treatments based on genomic variants
- communicating with patients about their results
CNE Information and Disclosures
- Identify patients who are appropriate candidates for tumor genomic testing
- Identify actionable information on a report
- Recognize how tumor genomic testing is used to determine treatment
- Discuss benefits, risks, and limitations of tumor genomic testing in the patient context
CNE Approval Statement
This nursing continuing professional development activity was approved by the Northeast Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Criteria for Successful Completion
The learner must attend one or two sessions and complete an evaluation for each session attended.
Nurses are eligible for a maximum of 2.0 contact hours upon the completion of this activity.
Conflict of Interest Disclosure
This educational activity does not include any content that relates to the products and/or services of a commercial interest that would create a conflict of interest. Unless otherwise noted, the program planners and faculty do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this program.
There is no commercial support being received for this event.
June 17, 2020 1-2 pm EDT
- Introduction: How genomics is relevant in the cancer patient's journey
- Identifying candidates for testing
- Communicating with patients about genomic tumor testing
June 24, 2020 1-2 pm EDT
- Navigating a genomic tumor report
- Matching genomic variants to treatment options
- Putting it all together: Identifying patient messages about genomic tumor testing
Participation in both sessions is encouraged.
Emily Edelman, MS, CGC, Associate Director, Clinical & Continuing Education Program, The Jackson Laboratory
Kate Reed, ScM, CGC, MPH, Director, Clinical & Continuing Education Program, The Jackson Laboratory
Jens Rueter, MD, Medical Director, Maine Cancer Genomics Initiative, The Jackson Laboratory
Christine Walko, PharmD, Associate Member, Individualized Cancer Management, Moffit Cancer Center